Evidence map›Paper›PMID 36233972›Full record

ArticleMaterials (Basel, Switzerland)2022

Synthesis and Corrosion Inhibition Potential of Cerium/Tetraethylenepentamine Dithiocarbamate Complex on AA2024-T3 in 3.5% NaCl.

Thi Huong Pham, Woo-Hyuk Lee, Gyeong-Ho Son, Trang Thu Tran, Jung-Gu Kim

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. REMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thi Huong PhamSchool of Advanced Materials Science and Engineering, Sungkyunkwan University, 2066, Seobu-Ro, Jangan-Gu, Suwon 440-746, Korea.
Woo-Hyuk LeeSchool of Advanced Materials Science and Engineering, Sungkyunkwan University, 2066, Seobu-Ro, Jangan-Gu, Suwon 440-746, Korea.ORCID 0000-0002-0112-3788
Gyeong-Ho SonSchool of Advanced Materials Science and Engineering, Sungkyunkwan University, 2066, Seobu-Ro, Jangan-Gu, Suwon 440-746, Korea.
Trang Thu TranDepartment of Energy Science, Sungkyunkwan University, 2066, Seobu-Ro, Jangan-Gu, Suwon 440-746, Korea.ORCID 0000-0001-8508-1652
Jung-Gu KimSchool of Advanced Materials Science and Engineering, Sungkyunkwan University, 2066, Seobu-Ro, Jangan-Gu, Suwon 440-746, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a cerium/tetraethylenepentamine dithiocarbamate complex was synthesized and evaluated for the corrosion inhibition capability on an AA2024-T3 Al alloy in a 3.5% NaCl medium. The synthesized compounds were characterized via spectroscopic techniques. The corrosion inhibition behaviour of the complex was elucidated by electrochemical measurements and surface analysis techniques. Based on electrochemical test results, the corrosion inhibition efficiency of the complex increases with the immersion time of aluminium alloy in the test solution. The corrosion inhibition reaches 96.80% when the aluminium is immersed in a 3.5% NaCl solution containing a corrosion inhibitor for 120 h. The potentiodynamic polarization test results show that the complex acts as a mixed-type corrosion inhibitor and the passive range is widened. The surface analysis methods reveal that the corrosion inhibition ability of the complex originated from the formation of a protective layer on the Al surface. This film is created from the physisorption and chemisorption of cerium ions and organic parts simultaneously released from the complex molecules.

Indexed as

alloyaluminiumcorrosion inhibitorpassive filmssynthesized inhibitorXPS

Identifiers

PMID36233972
PMCPMC9572790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.